Published in Water Res on April 02, 2005
A silica-supported iron oxide catalyst capable of activating hydrogen peroxide at neutral pH values. Environ Sci Technol (2009) 1.19
Dissolution of Mesoporous Silica Supports in Aqueous Solutions: Implications for Mesoporous Silica-based Water Treatment Processes. Appl Catal B (2012) 0.75
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev (1997) 4.09
Identification of new polypeptide species (48-55K) immunoprecipitable by antiserum to purified large T antigen and present in SV40-infected and -transformed cells. Virology (1979) 2.38
Catalytic wet peroxide oxidation of phenol by pillared clays containing Al-Ce-Fe. Water Res (2005) 2.25
Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. J Virol (1989) 2.17
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum Pathol (1992) 2.05
Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc Natl Acad Sci U S A (2001) 2.04
Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol (1994) 2.02
Prevalence of Leishmania infection among AIDS patients. Lancet (1992) 1.93
Monoclonal antibodies against influenza virus PB2 and NP polypeptides interfere with the initiation step of viral mRNA synthesis in vitro. J Virol (1994) 1.93
Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies. Virology (2000) 1.87
Host nuclear proteins expressed in simian virus 40-transformed and -infected cells. Proc Natl Acad Sci U S A (1980) 1.82
Air pollution and emergency room admissions for chronic obstructive pulmonary disease: a 5-year study. Am J Epidemiol (1993) 1.81
Adenoid cystic carcinoma of the breast: mammographic appearance and pathologic correlation. AJR Am J Roentgenol (1998) 1.73
Emerging trends in the seroprevalence of canine leishmaniasis in the Madrid region (central Spain). Vet Parasitol (2009) 1.69
Loss of conserved cysteine residues in the attachment (G) glycoprotein of two human respiratory syncytial virus escape mutants that contain multiple A-G substitutions (hypermutations). Virology (1994) 1.69
Synergistic sedation with propofol and midazolam in intensive care patients after coronary artery bypass grafting. Crit Care Med (1998) 1.63
Frame shift mutations as a novel mechanism for the generation of neutralization resistant mutants of human respiratory syncytial virus. EMBO J (1990) 1.59
Nuclear transport of influenza virus polymerase PA protein. Virus Res (1992) 1.59
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma. J Clin Oncol (1992) 1.55
Preventing asthma epidemics due to soybeans by dust-control measures. N Engl J Med (1993) 1.55
Phenotype correlation and intergenerational dynamics of the Friedreich ataxia GAA trinucleotide repeat. Am J Hum Genet (1997) 1.53
HIV co-infection with a currently non-pathogenic flagellate. Lancet (1996) 1.51
Current understanding and management of chronic hepatosplenic suppurative brucellosis. Clin Infect Dis (2001) 1.51
Premature stop codons in the G glycoprotein of human respiratory syncytial viruses resistant to neutralization by monoclonal antibodies. J Virol (1991) 1.50
Antigenic structure of human respiratory syncytial virus fusion glycoprotein. J Virol (1998) 1.50
Risk factors for high-order multiple implantation after ovarian stimulation with gonadotrophins: evidence from a large series of 1878 consecutive pregnancies in a single centre. Hum Reprod (2001) 1.49
Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants. J Gen Virol (1997) 1.49
Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia. J Exp Med (1998) 1.48
Epidural anaesthesia for ureteral reimplantation in an infant with congenital tracheal stenosis. Can J Anaesth (1997) 1.43
Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy. Ann Trop Med Parasitol (1994) 1.42
Value of PSA (prostate-specific antigen) in the detection of prostate cancer in patients with urological symptoms. Results of a multicentre study. Eur J Cancer (1996) 1.41
Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion. Invest New Drugs (1990) 1.40
Autologous peripheral blood stem cell transplantation (PBSCT) mobilized with G-CSF in AML in first complete remission. Role of intensification therapy in outcome. Bone Marrow Transplant (1998) 1.40
Antenatal phenobarbital for the prevention of periventricular and intraventricular hemorrhage: a double-blind, randomized, placebo-controlled, multihospital trial. J Pediatr (1990) 1.38
Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis. Infect Immun (2003) 1.38
Characterization of a human astrovirus serotype 2 structural protein (VP26) that contains an epitope involved in virus neutralization. Virology (1994) 1.37
Antiserum to polyacrylamide gel-purified simian virus 40 T antigen. Virology (1978) 1.36
Unique amino acid substitutions in the capsid proteins of foot-and-mouth disease virus from a persistent infection in cell culture. J Virol (1990) 1.35
Analysis of genetic variability in human respiratory syncytial virus by the RNase A mismatch cleavage method: subtype divergence and heterogeneity. Virology (1990) 1.33
Membrane permeability changes induced in Escherichia coli by the SH protein of human respiratory syncytial virus. Virology (1997) 1.31
Isolation of cross-reactive, subtype-specific monoclonal antibodies against influenza virus HA1 and HA2 hemagglutinin subunits. Arch Virol (1987) 1.31
Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans. J Gen Virol (2000) 1.28
Efficacy and safety of two new methods of rapid intravenous detoxification in heroin addicts previously treated without success. Br J Psychiatry (1997) 1.27
In vitro reconstitution of active influenza virus ribonucleoprotein complexes using viral proteins purified from infected cells. J Gen Virol (1992) 1.26
Location of a highly conserved neutralizing epitope in the F glycoprotein of human respiratory syncytial virus. J Virol (1990) 1.26
Participation of cytoskeletal intermediate filaments in the infectious cycle of human respiratory syncytial virus (RSV). Virus Res (1988) 1.25
Seasonal trends and spatial relations between environmental/meteorological factors and leishmaniosis sand fly vector abundances in Central Spain. Acta Trop (2010) 1.24
Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies. Hum Genet (1997) 1.24
Nucleotide sequence of the fusion and phosphoprotein genes of human respiratory syncytial (RS) virus Long strain: evidence of subtype genetic heterogeneity. Virus Res (1988) 1.23
NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors. Carcinogenesis (2000) 1.21
Application and evaluation of QBC malaria diagnosis in a holoendemic area. Appl Parasitol (1994) 1.21
An antigen-binding assay to determine the specificity of monoclonal antibodies against influenza virus and mapping of epitopes. J Virol Methods (1986) 1.21
Analysis of genetic variability and mapping of point mutations in influenza virus by the RNase A mismatch cleavage method. Proc Natl Acad Sci U S A (1988) 1.21
Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein. J Gen Virol (1993) 1.19
Detection of known and novel genomic rearrangements by array based comparative genomic hybridisation: deletion of ZNF533 and duplication of CHARGE syndrome genes. J Med Genet (2008) 1.17
Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains. J Med Virol (2000) 1.17
Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss. Eye (Lond) (2008) 1.13
Evolutionary pattern of the G glycoprotein of human respiratory syncytial viruses from antigenic group B: the use of alternative termination codons and lineage diversification. J Gen Virol (1999) 1.13
Prognostic value of CA 19.9 levels in colorectal cancer. Ann Surg (1992) 1.13
Parasitic culture of buffy coat for diagnosis of visceral leishmaniasis in human immunodeficiency virus-infected patients. J Clin Microbiol (1995) 1.12
The G protein of human respiratory syncytial virus: significance of carbohydrate side-chains and the C-terminal end to its antigenicity. J Gen Virol (1991) 1.12
X-chromosome tiling path array detection of copy number variants in patients with chromosome X-linked mental retardation. BMC Genomics (2007) 1.11
Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo. Infect Immun (1991) 1.10
Enhancement of the synthesis of specific cellular polypeptides in a temperature-sensitive Chinese hamster cell line (K12) defective for entry into S phase. J Cell Physiol (1978) 1.10
Preparation of monoclonal antibodies against glycoprotein IIIa of human platelets. Their effect on platelet aggregation. Eur J Biochem (1984) 1.09
Indirect xenodiagnosis of visceral leishmaniasis in 10 HIV-infected patients using colonized Phlebotomus perniciosus. AIDS (1994) 1.09
Epitope mapping of cross-reactive monoclonal antibodies specific for the influenza A virus PA and PB2 polypeptides. Virus Res (1995) 1.08
Identification of the glucose/glycosylation-regulated proteins as those which accumulate in the temperature-sensitive cell line K12. J Cell Physiol (1981) 1.08
Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients. Eur J Cancer (2009) 1.08
The role of indigenous phlebotomine sandflies and mammals in the spreading of leishmaniasis agents in the Mediterranean region. Euro Surveill (2013) 1.07
Host cell effect upon glycosylation and antigenicity of human respiratory syncytial virus G glycoprotein. Virology (1996) 1.06
Two types of inflammatory vascular disease in Sjögren's syndrome. Differential association with seroreactivity to rheumatoid factor and antibodies to Ro (SS-A) and with hypocomplementemia. Arthritis Rheum (1985) 1.06
Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein. J Immunol (1998) 1.05
Primary Sjögren's syndrome in men. Clinical, serologic, and immunogenetic features. Am J Med (1986) 1.05
A leishmaniosis surveillance system among stray dogs in the region of Madrid: ten years of serodiagnosis (1996-2006). Parasitol Res (2007) 1.05
Heavy metal speciation and phytotoxic effects of three representative sewage sludges for agricultural uses. Environ Pollut (2005) 1.04
Carcinoembryonic antigen in staging and follow-up of patients with solid tumors. Tumour Biol (1995) 1.04
Coordinate expression of the 48K host nuclear phosphoprotein and SV40 T ag upon primary infection of mouse cells. Virology (1980) 1.04
An autosomal dominant retinitis pigmentosa family with close linkage to D7S480 on 7q. Hum Genet (1995) 1.02
Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients. Gynecol Oncol (2000) 1.02
Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients. A cost-benefit analysis. Chest (1993) 1.00
Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and enolase activity and isoenzymes in lung, colon and liver carcinomas. Br J Cancer (1997) 1.00
The ground-dwelling arthropod community of Península Valdés in Patagonia, Argentina. J Insect Sci (2010) 0.99
Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery. Transfus Med (2006) 0.98
A primer vector system that allows temperature dependent gene amplification and expression in mammalian cells: regulation of the influenza virus NS1 gene expression. Nucleic Acids Res (1985) 0.98
Conformational studies of a short linear peptide corresponding to a major conserved neutralizing epitope of human respiratory syncytial virus fusion glycoprotein. Biopolymers (1996) 0.98
Oriented synthesis and cloning of influenza virus nucleoprotein cDNA that leads to its expression in mammalian cells. Virus Res (1985) 0.98
The three C-terminal residues of human respiratory syncytial virus G glycoprotein (Long strain) are essential for integrity of multiple epitopes distinguishable by antiidiotypic antibodies. Viral Immunol (1995) 0.98
Analysis of the 84K, 55K, and 48K proteins immunoprecipitable by SV40 T antibody from SV40-infected and -transformed cells by tryptic peptide mapping on cation-exchange columns. Virology (1981) 0.97
Variability of Leishmania (Leishmania) infantum among stocks from immunocompromised, immunocompetent patients and dogs in Spain. FEMS Microbiol Lett (1995) 0.97
Oligo(A) sequences of human respiratory syncytial virus G protein gene: assessment of their genetic stability in frameshift mutants. J Virol (1994) 0.96
Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients. J Clin Oncol (1997) 0.96
Human meiotic progression and recombination are affected by Bisphenol A exposure during in vitro human oocyte development. Hum Reprod (2011) 0.96
Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. Vox Sang (2005) 0.95